Kinase insert domain (KDR)-containing receptor is one of the human tyrosine kinases that has a high affinity for vascular endothelial growth factor (VEGF) and is believed to be a primary mediator of tumor-induced angiogenesis [1]. Compounds which influence the KDR kinase have attracted much attention and are of great interest as potential therapeutic agents. Several compounds with a quinazoline moiety have shown effective antitumor ...